The recently recognized class of membrane trafficking disorders (García‐Cazorla et al., 2022) such as that due to VPS33A mutations—mucopolysaccharidosis plus, [caused by deficiency of the HOPS complex], has pleiotropic clinical features. The gene discussed is VPS33A; the disease is mucopolysaccharidosis.